CD8A and neoplasm: The core concepts for successful therapeutic vaccination against tumors rely on two key factors: the selection of appropriate tumor antigens and a powerful vaccine platform eliciting high-quality CD8 T cells and CD4 T helper cells and the CTL infiltration of the tumor microenvironment (TME) and durable T cells responses [3] (Figure 1).